Jump to ContentJump to Main Navigation
Show Summary Details
More options …

International Journal of Adolescent Medicine and Health

Editor-in-Chief: Merrick, Joav

Editorial Board: Birch, Diana ML / Blum, Robert W. / Greydanus, MD, Dr. HC (Athens), Donald E. / Hardoff, Daniel / Kerr, Mike / Levy, Howard B / Morad, Mohammed / Omar, Hatim A. / de Paul, Joaquin / Rydelius, Per-Anders / Shek, Daniel T.L. / Sher, Leo / Silber, Tomas J. / Towns, Susan / Urkin, Jacob / Verhofstadt-Deneve, Leni / Zeltzer, Lonnie / Tenenbaum, Ariel


CiteScore 2018: 0.79

SCImago Journal Rank (SJR) 2018: 0.350
Source Normalized Impact per Paper (SNIP) 2018: 0.476

Online
ISSN
2191-0278
See all formats and pricing
More options …
Ahead of print

Issues

The prevalence of neuropathy among type 1 diabetic adolescents in Iran: a systematic review and meta-analysis

Aminolah Vasigh
  • Department of Anaesthesiology, Medicine Faculty, Ilam University of Medical Science, Ilam, Iran
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Alireza Abdi
  • Critical Care and Emergency Department, Nursing and Midwifery School, Kermanshah University of Medical Sciences, Kermanshah, Iran
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Milad Borji
  • Corresponding author
  • Critical Care and Emergency Department, Nursing and Midwifery School, Kermanshah University of Medical Sciences, Kermanshah, Iran
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Asma Tarjoman
Published Online: 2019-01-26 | DOI: https://doi.org/10.1515/ijamh-2018-0223

Abstract

Introduction

Neuropathy is one of the most common complications of diabetes, which causes many problems for diabetic patients. Thus, the aim of the present study was to investigate the prevalence of neuropathy among type 1 diabetic adolescents by systematic review and meta-analysis.

Materials and methods

This study is a systematic review and meta-analysis, which reviewed articles published from 2001 to September 1, 2018. The search process was carried out in the Google Scholar search engine and domestic and international databases such as Magiran, SID, Iranmedex, IranDoc, Medlib, PubMed, Scopus, Science Direct, Springer, Wiley Online Library, Web of Science, Ebsco and Cochrane using Persian and English keywords based on MESH conformity. All the research steps were carried out by two members of the research team who were familiar with systematic reviews and meta-analysis data, using the software CMA. Analysis of meta-regression and the use of a random effects model were introduced and analyzed.

Findings

When a systematic search was carried out on the reviewed articles, five of them were included in the meta-analysis phase. The sample size was 484, and the prevalence of diabetic peripheral neuropathy (DPN) in type 1 diabetic patients was 28.2% [confidence interval (CI) = 19.5–39.1]. The findings of the meta-regression analysis showed that the DPN prevalence rate decreased with increasing age (Q = 5.77 p = 0.016), and the results of more recent studies showed an increase in the DPN incidence rate (Q = 20.62, p < 0.001).

Conclusion

The findings of the present study revealed that although the prevalence of neuropathy in diabetic adolescents was not high, the prevalence was significant. Considering the increasing prevalence of diabetes and its impact on the health status of patients, appropriate interventions should be conducted to prevent diabetes and subsequent diabetic neuropathy.

Keywords: adolescents; diabetic neuropathy; systematic review and meta-analysis

References

  • [1]

    Mohammadi M, Raiegan V, Akbar A, Mirzaei M, Zahednezhad H, Jalali R, et al. Prevalence of underweight in Iranian children: a systematic review and meta-analysis. Tehran Univ Med J. 2018;76(4):241–9.Google Scholar

  • [2]

    Moţăţăianu A, Maier S, Bajko Z, Voidazan S, Bălaşa R, Stoian A. Cardiac autonomic neuropathy in type 1 and type 2 diabetes patients. BMC Neurol. 2018;18(1):126.CrossrefWeb of SciencePubMedGoogle Scholar

  • [3]

    Shohani M, Tavan H. Arbitrary use of insulin and its consequence. Iran J Public Health. 2018;47(8):1226–7.PubMedGoogle Scholar

  • [4]

    Cheraghi F, Mortazavi S, Shamsaei F, Moghimbeigi A. Effect of education on management of blood glucose in children with diabetes. J Nurs Educ. 2014;3(1):1–11.Google Scholar

  • [5]

    Esteghamati A, Larijani B, Aghajani MH, Ghaemi F, Kermanchi J, Shahrami A, et al. Diabetes in Iran: prospective analysis from first nationwide diabetes report of National Program for Prevention and Control of Diabetes (NPPCD-2016). Sci Rep. 2017;7(1):13461.Web of ScienceCrossrefPubMedGoogle Scholar

  • [6]

    Papatheodorou K, Banach M, Edmonds M, Papanas N, Papazoglou D. Complications of diabetes. J Diabetes Res. 2015;2015. DOI: .CrossrefGoogle Scholar

  • [7]

    De Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001;63(4):619–30.PubMedCrossrefGoogle Scholar

  • [8]

    Robinson MÈ, Altenor K, Carpenter C, Bonnell R, Jean‐Baptiste E, von Oettingen J. High rates of ocular complications in a cohort of Haitian children and adolescents with diabetes. Pediatr Diabetes. 2018;19(6):1124–1130. DOI: .CrossrefWeb of ScienceGoogle Scholar

  • [9]

    Feldman MA, Anderson LM, Shapiro JB, Jedraszko AM, Evans M, Weil LE, et al. Family-based interventions targeting improvements in health and family outcomes of children and adolescents with type 1 diabetes: a systematic review. Curr Diab Rep. 2018;18(3):15.CrossrefPubMedGoogle Scholar

  • [10]

    Moayeri A, Mohamadpour M, Mousavi SF, Shirzadpour E, Mohamadpour S, Amraei M. Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis. Ther Clin Risk Manag. 2017;13:455–68.Web of SciencePubMedCrossrefGoogle Scholar

  • [11]

    Amraei M, Mohamadpour S, Sayehmiri K, Mousavi SF, Shirzadpour E, Moayeri A. Effects of vitamin D deficiency on incidence risk of gestational diabetes mellitus: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2018;9:7.CrossrefPubMedGoogle Scholar

  • [12]

    Mutlu EK, Unver B, Taskiran H, Ozgen IT. An investigation of the foot ankle joint mobility, muscle strength, and foot structure in adolescent with type 1 diabetes. Int J Diabetes Dev Ctries. 2018;38(1):108–14.Web of ScienceCrossrefGoogle Scholar

  • [13]

    Elbarbary NS, Ismail EAR, El‐Naggar AR, Hamouda MH, El‐Hamamsy M. The effect of 12 weeks carnosine supplementation on renal functional integrity and oxidative stress in pediatric patients with diabetic nephropathy: a randomized placebo‐controlled trial. Pediatr Diabetes. 2018;19(3):470–7.CrossrefPubMedWeb of ScienceGoogle Scholar

  • [14]

    Peng S, Li C, Sun X. Complications of diabetes diagnosed in children and adolescents. J Am Med Assoc. 2017;317(24):2552–3.CrossrefGoogle Scholar

  • [15]

    Olfatifar M, Karami M, Shokri P, Hosseini SM. Prevalence of chronic complications and related risk factors of diabetes in patients referred to the diabetes center of Hamedan Province. Sci J Hamadan Nurs Midwifery Fac. 2017;25(2):69–74.CrossrefGoogle Scholar

  • [16]

    Alvarado-Martel D, Velasco R, Sánchez-Hernández RM, Carrillo A, Nóvoa FJ, Wägner AM. Quality of life and type 1 diabetes: a study assessing patients’ perceptions and self-management needs. Patient Prefer Adherence. 2015;9:1315–23.Web of SciencePubMedGoogle Scholar

  • [17]

    Stahl-Pehe A, Lange K, Bächle C, Castillo K, Holl RW, Rosenbauer J. Mental health problems among adolescents with early-onset and long-duration type 1 diabetes and their association with quality of life: a population-based survey. PLoS One. 2014;9(3):e92473.Web of SciencePubMedGoogle Scholar

  • [18]

    Castellano-Guerrero A, Guerrero R, Relimpio F, Losada F, Mangas M, Pumar A, et al. Prevalence and predictors of depression and anxiety in adult patients with type 1 diabetes in tertiary care setting. Acta Diabetol. 2018;55:943–53.PubMedCrossrefWeb of ScienceGoogle Scholar

  • [19]

    Schram MT, Baan CA, Pouwer F. Depression and quality of life in patients with diabetes: a systematic review from the European Depression in Diabetes (EDID) research consortium. Curr Diabetes Rev. 2009;5(2):112–9.CrossrefPubMedGoogle Scholar

  • [20]

    Trotta D, Verrotti A, Salladini C, Chiarelli F. Diabetic neuropathy in children and adolescents. Pediatr Diabetes. 2004;5(1):44–57.CrossrefPubMedGoogle Scholar

  • [21]

    Salvotelli L, Stoico V, Perrone F, Cacciatori V, Negri C, Brangani C, et al. Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: the Verona Diabetic Foot Screening Program. J Diabetes Complications. 2015;29(8):1066–70.PubMedCrossrefWeb of ScienceGoogle Scholar

  • [22]

    Kim SS, Won JC, Kwon HS, Kim CH, Lee JH, Park TS, et al. Prevalence and clinical implications of painful diabetic peripheral neuropathy in type 2 diabetes: results from a nationwide hospital-based study of diabetic neuropathy in Korea. Diabetes Res Clin Pract. 2014;103(3):522–9.CrossrefPubMedWeb of ScienceGoogle Scholar

  • [23]

    Louraki M, Katsalouli M, Kanaka-Gantenbein C, Kafassi N, Critselis E, Kallinikou D, et al. The prevalence of early subclinical somatic neuropathy in children and adolescents with Type 1 diabetes mellitus and its association with the persistence of autoantibodies to glutamic acid decarboxylase (GAD) and islet antigen-2 (IA-2). Diabetes Res Clin Pract. 2016;117:82–90.CrossrefPubMedWeb of ScienceGoogle Scholar

  • [24]

    Abbott CA, Malik RA, Ernest R, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetes population in the UK. Diabetes Care. 2011:34:2220–4.CrossrefGoogle Scholar

  • [25]

    Hasani N, Khosrawi S, Hashemipour M, Haghighatiyan M, Javdan Z, Taheri MH, et al. Prevalence and related risk-factors of peripheral neuropathy in children with insulin-dependent diabetes mellitus. J Res Med Sci. 2013;18(2):132–6.PubMedGoogle Scholar

  • [26]

    Ghaemi N, Hasanabadi H, Ashrafzadeh F, Sarvari S, Rahimi H, Hashemian S. Peripheral neuropathy in children and adolescents with insulin-dependent diabetes mellitus. Iran J Child Neurol. 2018;12(2):83–90.PubMedGoogle Scholar

  • [27]

    Sobhani S, Asayesh H, Sharifi F, Djalalinia S, Baradaran HR, Arzaghi SM, et al. Prevalence of diabetic peripheral neuropathy in Iran: a systematic review and meta-analysis. J Diabetes Metab Disord. 2014;13(1):97.PubMedCrossrefGoogle Scholar

  • [28]

    Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.Web of SciencePubMedCrossrefGoogle Scholar

  • [29]

    Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):e296.Web of ScienceGoogle Scholar

  • [30]

    Karamifar H, Mooadab M, Karamizadeh Z, Amirhakimi G. Evaluation of peripheral neuropathy in patients with type 1 diabetes mellitus by bedside scoring procedure. Iran J Pediatr. 2007;17(Suppl 1):54–60.Google Scholar

  • [31]

    Khorasani E. Prevalence of peripheral neuropathy and its related factors in diabetic children, Neishabour city, Iran. Int J Pediatr. 2018;6(12):8707–14.Web of ScienceGoogle Scholar

  • [32]

    Olfatifar M, Karami M, Hosseini SM, shokri P. Prevalence of chronic complications and related risk factors of diabetes in patients referred to the diabetes center of Hamedan Province. Sci J Hamadan Nurs Midwifery Fac. 2017;25(2):69–74.CrossrefGoogle Scholar

  • [33]

    Kiani J, Moghimbeigi A, Azizkhani H, Kosarifard S. The prevalence and associated risk factors of peripheral diabetic neuropathy in Hamedan, Iran. Arch Iran Med. 2013;16(1):17–9.PubMedGoogle Scholar

  • [34]

    Khawaja N, Abu-Shennar J, Saleh M, Dahbour SS, Khader YS, Ajlouni KM. The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan. Diabetol Metab Syndr. 2018;10(1):8.CrossrefPubMedWeb of ScienceGoogle Scholar

  • [35]

    Pop‐Busui R, Lu J, Lopes N, Jones TL. Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort. J Peripher Nerv Syst. 2009;14(1):1–13.Web of ScienceCrossrefPubMedGoogle Scholar

  • [36]

    Bai J-W, Lovblom LE, Cardinez M, Weisman A, Farooqi MA, Halpern EM, et al. Neuropathy and presence of emotional distress and depression in longstanding diabetes: results from the Canadian study of longevity in type 1 diabetes. J Diabetes Complications. 2017;31(8):1318–24.CrossrefPubMedWeb of ScienceGoogle Scholar

About the article

Received: 2018-09-27

Accepted: 2018-10-28

Published Online: 2019-01-26


Funding Source: Kermanshah University of Medical Sciences

Award identifier / Grant number: 3006963

This article was approved by the Student research committee of Kermanshah University of Medical Sciences with the Project Code 3006963, Funder Id: 10.13039/501100005317. Therefore, the researchers are grateful to the center.


Citation Information: International Journal of Adolescent Medicine and Health, 20180223, ISSN (Online) 2191-0278, DOI: https://doi.org/10.1515/ijamh-2018-0223.

Export Citation

©2019 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[2]
Somaye Pouy, Zahra Taheri Ezbarami, and Seyyed Zahra Shafipour
Journal of Comprehensive Pediatrics, 2019, Volume In Press, Number In Press
[3]
Ebrahim Naimi, Amin Babuei, Moslem Moslemirad, Karim Rezaei, and Owrang Eilami
Journal of Religion and Health, 2019

Comments (0)

Please log in or register to comment.
Log in